{"id":340324,"date":"2026-11-05T12:23:48","date_gmt":"2026-11-05T06:53:48","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/hester-biosciences-q2-results-fy27-pat-21-crore\/"},"modified":"2026-11-05T12:23:48","modified_gmt":"2026-11-05T06:53:48","slug":"hester-biosciences-q2-results-fy27-pat-21-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/hester-biosciences-q2-results-fy27-pat-21-crore\/","title":{"rendered":"Hester Biosciences Q2 Results FY27: Net Profit Jumps 43.96%, Revenue Rs 97.91 Cr, PAT Rs 20.63 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Hester Biosciences Q2 Results FY27 were declared on 5 November 2026. The Consolidated quarterly results show revenue of Rs 97.91 Cr against Rs 70.97 Cr a year earlier, which is YoY growth of 37.96%. Net profit rose 43.96% to Rs 20.63 Cr from Rs 14.33 Cr in the same quarter last year. The figures cover the July to September 2026 quarter.<\/p>\n<\/div>\n

Hester Biosciences Ltd<\/a> (HESTERBIO) Q2 Results FY27 announced on 5 November 2026, covering the company’s financial performance for the July to September quarter. Revenue stood at Rs 97.91 Cr and net profit (PAT) at Rs 20.63 Cr on a Consolidated basis. The results date anchors the comparison, and these consolidated results in Hester Biosciences Q2 Results FY27 sit against the same quarter a year earlier.<\/p>\n

This results analysis covers the financial highlights, business drivers, outlook and risks behind Hester Biosciences Q2 Results. Univest readers can start with the Financial Highlights table below, which sets the Consolidated quarter against the year-ago figures before the narrative breaks them down.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n